Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication

In this study, an optimized nanodispersible oral dosage form (containing a lactate ester) was developed for cilostazol (CZL). CZL is a phosphodiesterase inhibitor used for intermittent claudication. We aimed to improve the dissolution rate and absorption of CZL giving it a better chance of oral bioa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sallam, Marwa Ahmed, Marín Boscá, María Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508069/
https://www.ncbi.nlm.nih.gov/pubmed/26203244
http://dx.doi.org/10.2147/IJN.S83123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508069/
https://www.ncbi.nlm.nih.gov/pubmed/26203244
http://dx.doi.org/10.2147/IJN.S83123

Ejemplares similares